{"name":"Instituto Nacional de Salud Publica, Mexico","slug":"instituto-nacional-de-salud-publica-mexico","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bivalent Vaccines","genericName":"Bivalent Vaccines","slug":"bivalent-vaccines","indication":"Influenza prevention (bivalent formulations)","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Tetravalent Vaccine","genericName":"Tetravalent Vaccine","slug":"tetravalent-vaccine","indication":"Protection against four dengue serotypes (dengue tetravalent vaccine)","status":"marketed"}]}],"pipeline":[{"name":"Bivalent Vaccines","genericName":"Bivalent Vaccines","slug":"bivalent-vaccines","phase":"marketed","mechanism":"Bivalent vaccines stimulate immune responses against two distinct pathogenic targets or variants simultaneously.","indications":["Influenza prevention (bivalent formulations)","COVID-19 prevention (bivalent formulations against original and variant strains)"],"catalyst":""},{"name":"Tetravalent Vaccine","genericName":"Tetravalent Vaccine","slug":"tetravalent-vaccine","phase":"marketed","mechanism":"A tetravalent vaccine stimulates the immune system to produce antibodies and cellular immunity against four distinct pathogenic targets or strains.","indications":["Protection against four dengue serotypes (dengue tetravalent vaccine)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQRzc3QVVLMWR0TXF2bENUQzRkRTB5bmY4MXdLZWpwSTFxbjdXVXd1MXk3UTdTUXhwMGNWZDRQT2JpRThrN1d1MnNTcGZOLWdVdHc0ZUgzOG1saWxOODFQT3ZBenhxS1oySkVlSHExNGx4Q2JBQk1EdkY3THJxc0dlWjhoQ05RMmJvbUNwODQzczdTZjRtSXJGbDMyUFItMG9nMHdHT0gzU0l5cDJXM1NlZVNuSHdRZmFpRUpNZFdfZURjNUc0R2M3cg?oc=5","date":"2026-02-12","type":"pipeline","source":"Salud con lupa","summary":"El Estado compró más de 140 mil medicamentos oncológicos defectuosos que acabaron en la basura - Salud con lupa","headline":"El Estado compró más de 140 mil medicamentos oncológicos defectuosos que acabaron en la basura","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE0tWEc5b2s2ZVFST1p3WjhnR01CVGUyeWRHOEdSV0Y1c2RRNERXV1lCU0tIY3JtZ3ltQ3gzM2N3eVlURVNvNWN2WWU2LTZiZlRuaDh5ZE95YmhUWGFCaDVaRTJTSXdseVFiTWgtRGc0MlY1bWlR?oc=5","date":"2023-05-31","type":"pipeline","source":"Gob MX","summary":"Dr. Omar Yaxmehen Bello Chavolla - Gob MX","headline":"Dr. Omar Yaxmehen Bello Chavolla","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}